Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126378522 | 12637852 | 2 | F | 20160809 | 20160809 | 20160816 | EXP | JP-BAUSCH-BL-2016-018864 | BAUSCH AND LOMB | 60.00 | YR | M | Y | 0.00000 | 20160816 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126378522 | 12637852 | 1 | PS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | Y | 21119 | 15 | MG | INJECTION | |||||||
126378522 | 12637852 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 0 | .05 | ML | INJECTION | |||||||
126378522 | 12637852 | 3 | C | AFLIBERCEPT | AFLIBERCEPT | 1 | Other | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126378522 | 12637852 | 1 | Age-related macular degeneration |
126378522 | 12637852 | 2 | Age-related macular degeneration |
126378522 | 12637852 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126378522 | 12637852 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126378522 | 12637852 | Detachment of retinal pigment epithelium | |
126378522 | 12637852 | Subretinal fluid | |
126378522 | 12637852 | Vasodilatation | |
126378522 | 12637852 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |